Fanny Vincent

Fanny VINCENT is a seasoned regulatory affairs professional with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as the Global Regulatory Affairs Director at DBV Technologies since September 2014, Fanny is responsible for the regulatory strategy of combination products and oversees the writing and submission of various clinical trial authorization dossiers, engaging with regulatory authorities such as the FDA and EMA. Prior roles include Regulatory and Scientific Project Director at LYSOGENE, focusing on advanced therapy medicinal products, and a Project Manager at Laboratoires Servier. Fanny's educational background includes a PhD in Physiology, Molecular and Cell Biology, alongside master's and project management certificates.